Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical Trial.

Autor: Wong JS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Uno H; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Tramontano AC; Dana-Farber Cancer Institute, Boston, Massachusetts., Fisher L; Dana-Farber Cancer Institute, Boston, Massachusetts., Pellegrini CV; Dana-Farber Cancer Institute, Boston, Massachusetts., Abel GA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Burstein HJ; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Chun YS; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., King TA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Schrag D; Memorial Sloan Kettering Cancer Center, New York, New York., Winer E; Yale Cancer Center, New Haven, Connecticut., Bellon JR; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Cheney MD; Maine Medical Center, Portland, Maine., Hardenbergh P; Vail Health, Vail, Colorado., Ho A; Duke University Medical Center, Durham, North Carolina., Horst KC; Stanford University School of Medicine, Stanford, California., Kim JN; Fred Hutchinson Cancer Center/UW Medicine, Seattle, Washington., Leonard KL; Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Rhode Island Hospital, Providence., Moran MS; Yale Cancer Center, New Haven, Connecticut., Park CC; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Recht A; Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Soto DE; Massachusetts General Hospital, Boston., Shiloh RY; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Stinson SF; Johns Hopkins School of Medicine, Baltimore, Maryland., Snyder KM; Northern Light Health, Brewer, Maine., Taghian AG; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston., Warren LE; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Wright JL; Johns Hopkins School of Medicine, Baltimore, Maryland., Punglia RS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.

Publikováno v: JAMA oncology [JAMA Oncol] 2024 Oct 01; Vol. 10 (10), pp. 1370-1378.

" He's used drugs - he's biased! He's not a drug user - what would he know! ": A cross-sectional, online study of drug researchers' experiential knowledge of drug use and disclosure.

Autor: Ompad DC; Department of Epidemiology, School of Global Public Health, New York University, New York, NY, USA.; Center for Drug Use and HIV|HCV Research, School of Global Public Health, New York University, New York, NY, USA., Shrader CH; College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, USA.; Department of Epidemiology, School of Public Health, Columbia University, New York, NY, USA., Snyder KM; Department of Epidemiology, School of Global Public Health, New York University, New York, NY, USA., Netherland J; Drug Policy Alliance, New York, NY, USA., Vakharia SP; Drug Policy Alliance, New York, NY, USA., Walker I; School of Interdisciplinary Arts and Sciences, University of Washington, Tacoma, WA, USA.

Publikováno v: Drug and alcohol dependence reports [Drug Alcohol Depend Rep] 2024 Jul 08; Vol. 12, pp. 100256. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).

iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.

Autor: Snyder KM; Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, Minnesota, USA., Dixon KJ; Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, Minnesota, USA., Davis Z; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Hosking M; Fate Therapeutics Inc, San Diego, California, USA., Hart G; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Khaw M; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Matson A; Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, Minnesota, USA., Bjordahl R; Fate Therapeutics Inc, San Diego, California, USA., Hancock B; Fate Therapeutics Inc, San Diego, California, USA., Shirinbak S; Fate Therapeutics Inc, San Diego, California, USA., Miller JS; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Valamehr B; Fate Therapeutics Inc, San Diego, California, USA., Wu J; Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, Minnesota, USA., Walcheck B; Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, Minnesota, USA walch003@umn.edu.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Dec 06; Vol. 11 (12). Date of Electronic Publication: 2023 Dec 06.

The spatiotemporal dynamics of semantic integration in the human brain.

Autor: Murphy E; Vivian L. Smith Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. elliot.murphy@uth.tmc.edu.; Texas Institute for Restorative Neurotechnologies, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. elliot.murphy@uth.tmc.edu., Forseth KJ; Vivian L. Smith Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Texas Institute for Restorative Neurotechnologies, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Donos C; Faculty of Physics, University of Bucharest, Măgurele, 077125, Bucharest, Romania., Snyder KM; Vivian L. Smith Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Texas Institute for Restorative Neurotechnologies, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Rollo PS; Vivian L. Smith Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Texas Institute for Restorative Neurotechnologies, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Tandon N; Vivian L. Smith Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. nitin.tandon@uth.tmc.edu.; Texas Institute for Restorative Neurotechnologies, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. nitin.tandon@uth.tmc.edu.; Memorial Hermann Hospital, Texas Medical Center, Houston, TX, 77030, USA. nitin.tandon@uth.tmc.edu.

Publikováno v: Nature communications [Nat Commun] 2023 Oct 24; Vol. 14 (1), pp. 6336. Date of Electronic Publication: 2023 Oct 24.

Genomic profiling informs diagnoses and treatment in vascular anomalies.

Autor: Li D; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Lid2@chop.edu.; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Lid2@chop.edu.; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Lid2@chop.edu., Sheppard SE; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Unit on Vascular Malformations, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.; Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA., March ME; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Battig MR; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Surrey LF; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Srinivasan AS; Division of Interventional Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Matsuoka LS; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Tian L; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Wang F; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Seiler C; Zebrafish Core, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Dayneka J; Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Borst AJ; Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Matos MC; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Paulissen SM; Unit on Vascular Malformations, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA., Krishnamurthy G; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Nriagu B; Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Sikder T; Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Casey M; Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Williams L; Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Rangu S; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA., O'Connor N; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Thomas A; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Pinto E; Jill and Mark Fishman Center for Lymphatic Disorders, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Hou C; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Nguyen K; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Pellegrino da Silva R; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Chehimi SN; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Kao C; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Biroc L; Jill and Mark Fishman Center for Lymphatic Disorders, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Britt AD; Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Queenan M; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Reid JR; Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Napoli JA; Division of Plastic, Reconstructive, and Oral Surgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Low DM; Division of Plastic, Reconstructive, and Oral Surgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Vatsky S; Division of Interventional Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Treat J; Section of Dermatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Smith CL; Jill and Mark Fishman Center for Lymphatic Disorders, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Cahill AM; Division of Interventional Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Snyder KM; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Adams DM; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Dori Y; Jill and Mark Fishman Center for Lymphatic Disorders, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Hakonarson H; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. hakonarson@chop.edu.; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. hakonarson@chop.edu.; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. hakonarson@chop.edu.

Publikováno v: Nature medicine [Nat Med] 2023 Jun; Vol. 29 (6), pp. 1530-1539. Date of Electronic Publication: 2023 Jun 01.